Quarterly report pursuant to Section 13 or 15(d)

Organization, Basis of Presentation and Consolidation, and Significant Accounting Policies (Details)

v3.22.2.2
Organization, Basis of Presentation and Consolidation, and Significant Accounting Policies (Details)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended
Nov. 30, 2021
shares
Nov. 02, 2021
USD ($)
$ / shares
shares
Oct. 18, 2021
Sep. 30, 2022
USD ($)
Sep. 30, 2022
USD ($)
Sep. 30, 2021
USD ($)
Dec. 31, 2021
USD ($)
Subsidiary, Sale of Stock [Line Items]              
Reverse stock split ratio     0.06262040        
Unpaid deferred offering costs         $ 0 $ 2,975  
Exercises (in shares) | shares 2,424            
Tax expense       $ 800      
Tax receivable agreement liability       $ 211,438 $ 211,438   $ 210,639
IPO              
Subsidiary, Sale of Stock [Line Items]              
Sale of stock, number of shares issued (in shares) | shares   22,222,222          
Sale of stock, price (in dollars per share) | $ / shares   $ 19.00          
Sale of stock, consideration received   $ 393,500          
Underwriting discounts and commissions   23,200          
Unpaid deferred offering costs   $ 5,500